Nippon Express (UK) Receives IATA CEIV Pharma Certification for Its Facility in Heathrow Airport Suburb

TOKYO,April 25,2023 --Nippon Express (UK) Ltd. (hereinafter "NXUK"),a group company of NIPPONEXPRESS HOLDINGS,INC.,has been awarded IATA CEIV Pharma certification*,aquality certificate for pharmaceutical transport established by theInternational Air Transport Association (IATA),for its facility in the suburbsof Heathrow Airport,effective February 28 this year.

Logo: https://kyodonewsprwire.jp/img/202304184992-O1-JHM4p34o

Photo: Interior of facility that has obtained CEIV Pharma certification

https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202304184992/_prw_PI2fl_ER26fIgB.jpg?_ga=2.107928770.1572156177.1681692946-1430758024.1637027940

In addition to major global pharmaceutical companies,the United Kingdom ishome to numerous small and medium-sized biopharmaceutical companies as well as world-class universities and research institutes,making it a hub forpharmaceutical development and manufacturing. Demand for vaccines andtherapeutics has increased in recent years along with the COVID-19 pandemic,and imports and exports of pharmaceutical products via Heathrow Airport areexpected to continue rising in future.

The Nippon Express Group has positioned the pharmaceutical industry as a keyindustry in its "Nippon Express Group Business Plan 2023 -- Dynamic Growth,"and is pursuing the global development of a safe and secure pharmaceuticallogistics platform to meet the ever more sophisticated and diverse needs ofpharmaceutical logistics.

NXUK was awarded Good Distribution Practice (GDP) certification and WholesaleDistribution Authorisation (WDA) from the UK Medicines and Healthcare productsRegulatory Agency in April 2020,evidencing its compliance with internationallyrecognized standards for the proper distribution of pharmaceuticals,and,withthe acquisition of CEIV Pharma certification,will now be able to provide saferand higher-quality pharmaceutical transportation services using the UK,animportant hub for the pharmaceutical industry,as a nodal point.

The Nippon Express Group is committed to contributing to the health of peoplearound the world by supporting its customers in the global pharmaceuticalindustry from a logistics perspective through the establishment of a reliableand safe global pharmaceutical logistics platform.

*About CEIV Pharma:

https://kyodonewsprwire.jp/attach/202304184992-O1-eqntQrQm.pdf

Nippon Express website: https://www.nipponexpress.com/

Nippon Express Group's official LinkedIn account:

https://www.linkedin.com/company/nippon-express-group/